2021
|
Invention
|
(1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives... |
|
Invention
|
Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid.... |
|
Invention
|
Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid. ... |
|
Invention
|
Crystalline forms of 5-bromo-2,6-di(1h-pyrazol-1- yl)pyrimidin-4-amine and new salts. This applic... |
2018
|
Invention
|
Crystalline forms of 5-bromo-2,6-di(1h-pyrazol-1-yl)pyrimidin-4-amine and new salts. This applica... |
|
Invention
|
Amine salt of (1r, 3s)-3-(5-cyano-4-phenyl-1,3- thiazol-2-ylcarbamoyl)cyclopentane carboxylic aci... |
|
Invention
|
Amine salt of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid.... |
|
Invention
|
1-(4-amino-5-bromo-6-(1h-pyrazol-1-yl)pyrimidin-2-yl)-1h-pyrazol-4-ol and use thereof in the trea... |
|
Invention
|
1-(4-amino-5-bromo-6-(1 h-pyrazol-1-yl)pyrimidin-2-yl)-1 h-pyrazol-4-ol and use thereof in the tr... |
|
Invention
|
Adenosine a3 receptor modulators. 3 receptors of formula (I):
3 receptors.
|
|
Invention
|
Modulators of the adenosine a3 receptors. The invention relates to adenosine A3 receptor modulato... |
|
Invention
|
Adenosine a3 receptor modulators. The invention relates to adenosine A3 receptor modulators of fo... |
2016
|
Invention
|
5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer. The present... |
|
Invention
|
5-bromo-2,6-di-(lh-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer. The present... |
|
Invention
|
3 receptors. The present invention relates to novel pyridine derivatives of formula (I):
3 melat... |
|
Invention
|
Derivatives of 2-aminopyridine as adenosine a2b receptor antagonists and ligands of the melatonin... |
|
Invention
|
Modulators of the adenosine a3 receptors. 3 receptors of formula (I):
3 receptor.
|
|
Invention
|
Modulators of the adenosine a3 receptors. Modulators of adenosin A3 receptors of formula (I) and ... |
2014
|
Invention
|
Pyrimidine derivatives as phosphodiesterase 10 inhibitors (pde-10). The present invention relates... |
|
Invention
|
New pyrimidine derivatives as phosphodiesterase 10 inhibitors (pde-10). The present invention rel... |
2011
|
Invention
|
2a receptor antagonists. 2a receptor.
|
|
Invention
|
Aminopyrimidine derivatives and their use as adenosine a2a receptor antagonists. New 4-amino-pyri... |
|
Invention
|
4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists. New 4-amino-p... |
2008
|
Invention
|
1 receptor antagonists. 2 represents a group selected from: a) a straight or branched lower alkyl... |
|
Invention
|
New compounds as adenosine a1 receptor antagonists. This compounds correspond to the formu... |
|
Invention
|
New compounds as adenosine a1 receptor antagonists. This compounds correspond to the formula (I),... |
2006
|
Invention
|
Novel compounds as antagonists of adenosine a1 receptors. Compounds of formula (I), in which R1 r... |